Tag : Antiviral

Cardiology

Safety of antiviral and anti-inflammatory drugs prolonging QT interval in patients with coronavirus disease 2019: an opinion of the Heart Rhythm Section of the Polish Cardiac Society.

Newsemia
Related Articles Safety of antiviral and anti-inflammatory drugs prolonging QT interval in patients with coronavirus disease 2019: an opinion of the Heart Rhythm Section of...
Latest News

Antiviral effects of honeysuckle decoction affected in SIDT1poly population

Newsemia
Previously, Chen-Yu Zhang’s group have identified SID1 transmembrane family member 1 (SIDT1) as a critical membrane protein mediating dietary miRNAs absorption, which is abolished in...
Latest News

Gilead’s Investigational Antiviral Veklury® (Remdesivir) Receives U.S. Food and Drug Administration Emergency Use Authorization for the Treatment of Patients With Moderate COVID-19

Newsemia
FOSTER CITY, Calif.–(BUSINESS WIRE)–Gilead Sciences, Inc. (Nasdaq: GILD) today announced the U.S. Food and Drug Administration (FDA) expanded the Emergency Use Authorization (EUA) enabling use...
Latest News

SARS-CoV-2 hijacks antiviral factors to promote infection in human lung cells

Newsemia
Now, a new study published in the preprint server bioRxiv in August 2020 shows that under conditions resembling those in vivo, IFNs may promote efficient...
Neurology

NIAID Testing Remdesivir Plus MS Drug for COVID-19

Newsemia
The ACTT-3 randomized controlled trial is testing the safety and efficacy remdesivir in combination with the immunomodulator interferon beta-1a in hospitalized COVID-19 patients. Medscape Medical...
AI/ML

Predicting commercially available antiviral drugs that may act on the novel coronavirus (SARS-CoV-2) through a drug-target interaction deep learning model.

Newsemia
Related Articles Predicting commercially available antiviral drugs that may act on the novel coronavirus (SARS-CoV-2) through a drug-target interaction deep learning model. Comput Struct Biotechnol...
Pharma / Biotech

Repositioning chloroquine as antiviral prophylaxis against COVID-19: potential and challenges.

Newsemia
Related Articles Repositioning chloroquine as antiviral prophylaxis against COVID-19: potential and challenges. Drug Discov Today. 2020 Jul 03;: Authors: Chang R, Sun WZ Abstract The...
Gastroenterology

JNJ-56136379, an HBV Capsid Assembly Modulator, is Well-Tolerated and Has Antiviral Activity in a Phase 1 Study of Patients with Chronic Infection

Newsemia
JNJ-56136379 (JNJ-6379), a capsid assembly modulator that blocks hepatitis B virus (HBV) replication, was well tolerated and demonstrated dose-proportional pharmacokinetics in healthy participants in part...
Neurology

COVID-19 Update: Fauci Warns of 100K Cases/Day, HCQ Trial to Resume

Newsemia
The coronavirus stories Medscape’s editors around the globe think you need to know about today. Medscape Medical News Source link...
Latest News

CORRECTING and REPLACING Disinfect&Shield™ Launches FDA-Registered Sanitizer and EPA-Registered Long-Lasting, Eco-Friendly, Anti-Viral Disinfectants That Kill 99.99% Of Bacteria and Viruses on Contact, Creating A Continuous Surface Defense

Newsemia
NEW YORK–(BUSINESS WIRE)–Please replace the release dated April 15, 2020 with the following corrected version due to multiple revisions. The corrected release reads: DISINFECT&SHIELD™ LAUNCHES...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy

COVID-19

COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World